Cat. No. 5790
Chemical Name: 1,4-Dihydro-1'-[2-methyl-1H-benzimid
Biological ActivityAcetyl-CoA carboxylase (ACC) 2 and 1 inhibitor (IC50 values are 45 and 98 nM, respectively). Reduces hepatic and skeletal muscle malonyl-CoA levels in rats. Also inhibits hepatic de novo lipogenesis and reduces whole body respiratory exchange ratio in rats. Orally bioavailable.
Licensing InformationSold for research purposes under agreement from Pfizer Inc.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Griffith et al (2014) Decreasing the rate of metabolic ketone reduction in the discovery of a clinical acetyl-CoA carboxylase inhibitor for the treatment of diabetes. J.Med.Chem. 57 10512. PMID: 25423286.
If you know of a relevant reference for PF 05175157 please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses PF 05175157 from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: PF 05175157, supplier, PF05175157, Acetyl, CoA, carboxylase, 1, 2, inhibitors, inhibits, ACC1, ACC2, orally, bioavailable, type, 2, diabetes, mellitus, Tocris Bioscience, Other Lipid Metabolism Inhibitor products